Treating T2DM and obesity with bariatric surgery and GLP1 agents

Clifford J. Bailey

doi:10.1038/s41574-019-0240-4

Treating T2DM and obesity with bariatric surgery and GLP1 agents

Clifford J. Bailey^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter, comment/opinion or interview › peer-review

4 Citations (Scopus)

Abstract

Bariatric surgery often produces remission of hyperglycaemia in patients with coexistent obesity and type 2 diabetes mellitus, but the hyperglycaemia is prone to return years later. A prospective study demonstrates that therapy with a glucagon-like peptide 1 receptor agonist can reinstate normal glycaemic control in many of these patients.

Original language	English
Pages (from-to)	504–506
Number of pages	3
Journal	Nature Reviews Endocrinology
Volume	15
Issue number	9
DOIs	https://doi.org/10.1038/s41574-019-0240-4
Publication status	Published - 22 Jul 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1038/s41574-019-0240-4

Cite this

@article{110f3e13ce9745cda04982dfaca97bf8,

title = "Treating T2DM and obesity with bariatric surgery and GLP1 agents",

abstract = "Bariatric surgery often produces remission of hyperglycaemia in patients with coexistent obesity and type 2 diabetes mellitus, but the hyperglycaemia is prone to return years later. A prospective study demonstrates that therapy with a glucagon-like peptide 1 receptor agonist can reinstate normal glycaemic control in many of these patients.",

author = "Bailey, \{Clifford J.\}",

year = "2019",

month = jul,

day = "22",

doi = "10.1038/s41574-019-0240-4",

language = "English",

volume = "15",

pages = "504–506",

journal = "Nature Reviews Endocrinology",

issn = "1759-5029",

publisher = "Nature Publishing Group",

number = "9",

}

TY - JOUR

T1 - Treating T2DM and obesity with bariatric surgery and GLP1 agents

AU - Bailey, Clifford J.

PY - 2019/7/22

Y1 - 2019/7/22

N2 - Bariatric surgery often produces remission of hyperglycaemia in patients with coexistent obesity and type 2 diabetes mellitus, but the hyperglycaemia is prone to return years later. A prospective study demonstrates that therapy with a glucagon-like peptide 1 receptor agonist can reinstate normal glycaemic control in many of these patients.

AB - Bariatric surgery often produces remission of hyperglycaemia in patients with coexistent obesity and type 2 diabetes mellitus, but the hyperglycaemia is prone to return years later. A prospective study demonstrates that therapy with a glucagon-like peptide 1 receptor agonist can reinstate normal glycaemic control in many of these patients.

UR - https://www.scopus.com/pages/publications/85070328304

UR - https://www.nature.com/articles/s41574-019-0240-4

U2 - 10.1038/s41574-019-0240-4

DO - 10.1038/s41574-019-0240-4

M3 - Letter, comment/opinion or interview

C2 - 31332303

AN - SCOPUS:85070328304

SN - 1759-5029

VL - 15

SP - 504

EP - 506

JO - Nature Reviews Endocrinology

JF - Nature Reviews Endocrinology

IS - 9

ER -

Treating T2DM and obesity with bariatric surgery and GLP1 agents

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this